# Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

> **NCT06054269** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Centers for Disease Control and Prevention** · enrollment: 192 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** FLUAD Quadrivalent
- **BIOLOGICAL:** FluQuadri

## Key facts

- **NCT ID:** NCT06054269
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-04
- **Primary completion:** 2023-07-25
- **Final completion:** 2026-03-31
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2025-05-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06054269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06054269, "Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06054269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*